<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03815435</url>
  </required_header>
  <id_info>
    <org_study_id>KARIM-01-ENSURGERY</org_study_id>
    <nct_id>NCT03815435</nct_id>
  </id_info>
  <brief_title>The Influence of Blood Pressure Upon the Clarity of Surgical Field in Endonasal Surgery</brief_title>
  <official_title>The Influence of Blood Pressure Upon the Clarity of Surgical Field in Endonasal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The work compares the effect of different techniques of anesthesia on the clarity of the
      surgical field in pansinusoperation in patients with chronic rhinosinusitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The work compares the effect of different anaesthesia techniques on the clarity of the
      surgical field in pansinusoperation in patients with chronic rhinosinusitis. Balanced
      anaesthesia using volatile anaesthetics (Desflurane + Sufentanil) is compared to total
      intravenous anaesthesia (Propofol + Sufentanil). A secondary goal of the study is to compare
      circulatory parameters, depth of anaesthesia and consumption of hypotensives in these two
      groups of patients.

      Null hypothesis: There is no difference in the clarity of the surgical field at various
      levels of the mean arterial pressure.

      This study is being realized in accordance with the Declaration of Helsinki and has been
      approved by the Ethics Committee of the University Hospital Ostrava (849/2018). According to
      the statement of the State Institute for Drug Control of 26th April 2019 (reference number
      Sukl96964/2019), the trial is not considered a clinical trial of medicinal products.

      Study type: Single-blind study (the surgeon does not know the value of the patient's blood
      pressure) prospective observational study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study subjects will be randomized into two study arms.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The physician performing the surgery and assessing the surgical field clarity will be masked as to what type of anaesthesia has been used in the individual patient.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical field clarity in relation to the value of mean arterial pressure</measure>
    <time_frame>13 months</time_frame>
    <description>Clarity of the surgical field will be assessed on a scale of 0-5, according to the Boezaart's system (1995)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>13 months</time_frame>
    <description>Blood pressure will be measured in the morning before surgery, on arrival at the operating theatre and further 5 minutes after anaesthesia, and every five minutes during the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>13 months</time_frame>
    <description>Heart rate will be measured in the morning before surgery, on arrival at the operating theatre and further 5 minutes after anaesthesia, and every five minutes during the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depth of anaesthesia</measure>
    <time_frame>13 months</time_frame>
    <description>Depth of anaesthesia will be measured using the BIS value every 5 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of hypotensives</measure>
    <time_frame>13 months</time_frame>
    <description>Consumption of hypotensives (Nitro Pohl) will be measured in mg/hr</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>13 months</time_frame>
    <description>Blood loss (ml) during the surgery will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance length</measure>
    <time_frame>13 months</time_frame>
    <description>The interval from the end of surgery to eye opening in minutes will be measured.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>13 months</time_frame>
    <description>Postoperative pain will be measured using the VAS (Visual Analogue Scale) upon arrival to the recovery room and the standard ward.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>13 months</time_frame>
    <description>The standardised clock-drawing test will be performed at the ward, 2 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea</measure>
    <time_frame>13 months</time_frame>
    <description>The presence of postoperative nausea (YES/NO) will be observed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative vomiting</measure>
    <time_frame>13 months</time_frame>
    <description>The presence of postoperative vomiting (YES/NO) will be observed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficult to control hypotension</measure>
    <time_frame>13 months</time_frame>
    <description>The presence of difficult to control hypotension (stroke, myocardial infarction, kidney injury - YES/NO) will be observed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of tamponade</measure>
    <time_frame>13 months</time_frame>
    <description>The need to use tamponade due to bleeding (YES/NO) will be observed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical bleeding</measure>
    <time_frame>13 months</time_frame>
    <description>The need for surgical revision due to bleeding (YES/NO) will be observed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Chronic Rhinosinusitis (Diagnosis)</condition>
  <arm_group>
    <arm_group_label>Balanced anaesthesia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction of anaesthesia: Sufentanil ( 0.2ug/ kg) + Propofol (2-3 mg /kg) + Rocuronium (0.6 mg/kg) Management of anaesthesia: Desflurane 0.8-1.2 MAC + Sufentanil boluses of 10 ug as needed. The target BIS value: 40-60</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total intravenous anaesthesia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction of anaesthesia: Sufentanil ( 0.2ug/kg) + Propofol (2 -3 mg /kg) + Rocuronium (0.6 mg/kg) Management of anaesthesia: continuous administration of Propofol 6-12 mg /kg/h + Sufentanil boluses of 10 ug as needed. The target BIS value: 40-60 Hypotensives: Nitro Pohl 1mg/ml 0-10 ml/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total intravenous anaesthesia</intervention_name>
    <description>Induction of anaesthesia: Sufentanil ( 0.2ug/kg) + Propofol (2 -3 mg /kg) + Rocuronium (0.6 mg/kg) Management of anaesthesia: continuous administration of Propofol 6-12 mg /kg/h + Sufentanil boluses of 10 ug as needed. The target BIS value: 40-60 Hypotensives: Nitro Pohl 1mg/ml 0-10 ml/h</description>
    <arm_group_label>Total intravenous anaesthesia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Balanced anaesthesia group</intervention_name>
    <description>Induction of anaesthesia: Sufentanil ( 0.2ug/ kg) + Propofol (2-3 mg /kg) + Rocuronium (0.6 mg/kg) Management of anaesthesia: Desflurane 0.8-1.2 MAC + Sufentanil boluses of 10 ug as needed. The target BIS value: 40-60</description>
    <arm_group_label>Balanced anaesthesia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chronic rhinosinusitis undergoing pansinusoperation

          -  Age over 18 years

          -  Concrete surgeon (Petr Matou≈°ek, MD, Ph.D., MBA)

          -  Concrete anaesthetist (Michal Parma, MD)

        Exclusion Criteria:

          -  Coagulopathy

          -  Thrombocytopathies

          -  Vascular wall disorders

          -  Thrombophlebitis

          -  Anticoagulation or anti-aggregation therapy

          -  History of malignancy

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ond≈ôej Jor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>70852</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <reference>
    <citation>Thongrong C, Kasemsiri P, Carrau RL, Bergese SD. Control of bleeding in endoscopic skull base surgery: current concepts to improve hemostasis. ISRN Surg. 2013 Jun 13;2013:191543. doi: 10.1155/2013/191543. Print 2013.</citation>
    <PMID>23844295</PMID>
  </reference>
  <reference>
    <citation>Kelly EA, Gollapudy S, Riess ML, Woehlck HJ, Loehrl TA, Poetker DM. Quality of surgical field during endoscopic sinus surgery: a systematic literature review of the effect of total intravenous compared to inhalational anesthesia. Int Forum Allergy Rhinol. 2013 Jun;3(6):474-81. doi: 10.1002/alr.21125. Epub 2012 Dec 19. Review.</citation>
    <PMID>23258603</PMID>
  </reference>
  <reference>
    <citation>Athanasiadis T, Beule A, Embate J, Steinmeier E, Field J, Wormald PJ. Standardized video-endoscopy and surgical field grading scale for endoscopic sinus surgery: a multi-centre study. Laryngoscope. 2008 Feb;118(2):314-9.</citation>
    <PMID>17989575</PMID>
  </reference>
  <reference>
    <citation>Mi≈Ço≈Ñski J, Zieli≈Ñska-Bli≈∫niewska H, Golusi≈Ñski W, Urbaniak J, Soba≈Ñski R, Olszewski J. Effects of three different types of anaesthesia on perioperative bleeding control in functional endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2013 Jul;270(7):2045-50. doi: 10.1007/s00405-012-2311-1. Epub 2012 Dec 22.</citation>
    <PMID>23263204</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 21, 2019</study_first_submitted>
  <study_first_submitted_qc>January 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2019</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Surgical field clarity</keyword>
  <keyword>Endonasal surgery</keyword>
  <keyword>Intraoperative bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The investigators have not decided to share the individual participant data with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

